Last reviewed · How we verify
NCT04242212
Study of Clinic-based vs. Self-use of a Misoprostol-only Regimen for Induced Abortion
trial testing Misoprostol sourced from clinics in Induced Abortion in 4,000 participants. Status unknown.
30 June 2020
Quick facts
| Lead sponsor | Ipas |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 4,000 |
| Start date | 19 May 2019 |
| Primary completion | 30 June 2020 |
| Estimated completion | 30 June 2020 |
| Sites | 3 locations across Nigeria |
Drugs / interventions tested
- Misoprostol sourced from clinics
- Misoprostol sourced from PMVs
Conditions studied
- Induced Abortion — all drugs for Induced Abortion →
- First Trimester Abortion — all drugs for First Trimester Abortion →
Sponsor
Ipas — full company profile →
Who can join
Adults 15 to 49, female only, with Induced Abortion or First Trimester Abortion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of the study is to determine whether important clinical outcomes differ among women who access a misoprostol-only medication abortion regimen from a patent medicine vendor when compared with those who access it from a clinic.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Self-managed medical abortion in Nigeria: a prospective, comparative study of clinical outcomes for a misoprostol-alone regimen obtained from patent medicine vendors compared to clinics.
Shellenberg KM, Storey S, Griffin R, Okwesa N, et al · · 2026 · PMID 41888911 · DOI 10.1186/s12978-026-02305-0 -
Self-managed medical abortion in Nigeria: A prospective, comparative study of clinical outcomes for a misoprostol-alone regimen obtained from patent medicine vendors compared to clinics
Shellenberg KM, Griffin R, Storey S, Okwesa N, et al · · 2025 · DOI 10.21203/rs.3.rs-7652351/v1
Verify or expand the search:
- PubMed search for NCT04242212
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Ipas trials
Trials by the same sponsor.
- NCT04181541 — Midlevel Versus Physician-provided Medical Abortion in the Second Trimester · NA · completed
- NCT04290832 — Developing and Testing Interventions to Address Conscientious Objection to Abortion Care in Mexico and South Africa · NA · terminated
- NCT03539315 — Adaptation and Testing of the Addressing Reproductive Coercion in HEalth Settings (ARCHES) Intervention in Bangladesh · NA · completed
- NCT03727308 — Study of Clinic-based Versus Self-use of Medical Abortion Pills · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04242212 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ipas
- Last refreshed: 24 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04242212.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing